Transition Gets Go-Ahead for Clinical Trials of Alzheimer's Drug | INS News

Transition Gets Go-Ahead for Clinical Trials of Alzheimer's Drug: "Transition Therapeutics has received clearance from the FDA to initiate a phase I clinical trial for its lead Alzheimer's drug product, AZD-103."